Mary's Medicinals Announces Its Intention to Participate in the Newly Announced Medicare and Medicaid CMS Trial Program with Its Award-Winning Cannabinoid-Based Wellness Products

DENVER, April 1, 2026 /PRNewswire/ -- Mary's Medicinals, a subsidiary of MM Brands Inc. (MM Brands), officially announced today its intent to participate in the newly established Centers for Medicare & Medicaid Services (CMS) cannabinoid therapy trial program. Launched today under the CMS...